UPDATE : Wednesday, August 21, 2019
상단여백
Pharmaceutical industry leading new growth in Korea: report
The pharmaceutical industry is leading technological innovation and knowled...
by Nam Doo-hyun  |  2017-09-18 14:50
라인
Opdivo adds one more melanoma indication
Ono Pharma Korea and Bristol-Myers Squibb Korea said Monday their anti PD-1...
by Marian Chu  |  2017-09-18 11:34
라인
Korean pharmaceuticals challenge Pfizer’s Viviant with combination drugs
South Korean pharmaceutical firms are seeking ways to develop combination d...
by Lee Hye-seon  |  2017-09-18 11:26
라인
HIRA’s drug pricing allegedly favors Green Cross, PMG Korea
The Korea Medical Clinic Association said Friday the Health Insurance Revie...
by Song Soo-youn  |  2017-09-15 17:58
라인
Kolon uses Invossa to attract foreign patients
Kolon Life Science said it made a strategic MOU with Korea Tour Promotion A...
by Lee Hye-seon  |  2017-09-15 17:49
라인
SK Chemicals’ release of test result abroad raises curiosity
SK Chemicals has released the results of its clinical trials of the overact...
by Lee Hye-seon  |  2017-09-15 17:39
라인
Hanmi releases research result of new bio drug in Europe
Hanmi Pharmaceutical released the results of two new bio drugs the company ...
by Lee Hye-seon  |  2017-09-15 14:32
라인
LG Chem promotes antidiabetic Zemiglo in Europe
LG Chemical has launched a symposium to promote its antidiabetics drug Zemi...
by Lee Hye-seon  |  2017-09-15 11:51
라인
In historic move, FDA approves 1st biosimilar to treat cancer
The U.S. Food and Drug Administration Thursday marked a new page in cancer ...
by Marian Chu  |  2017-09-15 11:40
라인
Huons to build new office
Huons Global said Wednesday that it plans to move its headquarters and R&D ...
by Lee Han-soo  |  2017-09-15 10:29
라인
Daewoong wins rights to market hepatitis B treatment
Daewoong Pharmaceuticals대웅제약 (President Lee Jong-wook이종욱) said Thursday tha...
by Constance Williams  |  2017-09-14 19:37
라인
NOAC race: Pradaxa prescription numbers fall behind fast followers
The first product to gain indications for a disease often maintains a domin...
by Marian Chu  |  2017-09-14 19:02
라인
Opdivo vs. Keytruda - which will doctors choose?
Two blockbuster immunotherapies Opdivo and Keytruda gained insurance covera...
by Marian Chu  |  2017-09-14 17:54
라인
Chong Kun Dang enters an osteoporosis therapy market
Chong Kun Dang has entered an osteoporosis therapy market with Prolia (comp...
by Lee Hye-seon  |  2017-09-14 17:53
라인
AstraZeneca regains momentum with positive Imfinzi results
Astra Zeneca Korea said Thursday it had some good news from its phase 3 Pac...
by Marian Chu  |  2017-09-14 13:34
라인
Amgen, Chong Kun Dang to sell osteoporosis drug in Korea
Amgen Korea said it signed a joint promotion agreement with Korean pharmace...
by Marian Chu  |  2017-09-13 18:33
라인
Alvogen Korea to sell Vivus’ obesity drug
Alvogen Korea said Wednesday that it gained exclusive marketing rights to s...
by Marian Chu  |  2017-09-13 18:16
라인
ASEAN officials visit JW’s manufacturing plant
Officials involved in good manufacturing practice (GMP) in 10 member nation...
by Song Soo-youn  |  2017-09-13 18:07
라인
Opdivo’s expanded indications ease cancer patients’ worries
Ono Pharma Korea and Bristol-Myers Squibb said Wednesday that their blockbu...
by Marian Chu  |  2017-09-13 16:57
라인
Anticoagulant drugs will add SJS Warning
The approval conditions of nine medicines that include rivaroxaban, such as...
by Lee Hye-seon  |  2017-09-13 15:55
여백
여백
여백
Back to Top